IRIS
AVOLIO, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.355
EU - Europa 3.721
AS - Asia 2.641
SA - Sud America 507
AF - Africa 58
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 11
Totale 11.313
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.276
SG - Singapore 1.025
IE - Irlanda 888
CN - Cina 791
RU - Federazione Russa 569
UA - Ucraina 486
IT - Italia 430
BR - Brasile 409
SE - Svezia 389
HK - Hong Kong 285
DE - Germania 272
FR - Francia 256
VN - Vietnam 176
FI - Finlandia 155
GB - Regno Unito 98
IN - India 98
TR - Turchia 68
BD - Bangladesh 63
AR - Argentina 39
BE - Belgio 39
CA - Canada 37
NL - Olanda 28
AT - Austria 25
MX - Messico 19
ES - Italia 18
ID - Indonesia 18
PL - Polonia 18
ZA - Sudafrica 17
IQ - Iraq 16
EU - Europa 15
VE - Venezuela 15
JP - Giappone 14
EC - Ecuador 13
IR - Iran 13
PK - Pakistan 12
CL - Cile 10
CZ - Repubblica Ceca 10
AU - Australia 8
CR - Costa Rica 8
CO - Colombia 7
PT - Portogallo 7
TN - Tunisia 7
JO - Giordania 6
MA - Marocco 6
SC - Seychelles 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
LT - Lituania 5
PH - Filippine 5
PY - Paraguay 5
SA - Arabia Saudita 5
XK - ???statistics.table.value.countryCode.XK??? 5
BO - Bolivia 4
DZ - Algeria 4
HN - Honduras 4
MY - Malesia 4
CH - Svizzera 3
EG - Egitto 3
GT - Guatemala 3
HR - Croazia 3
HU - Ungheria 3
JM - Giamaica 3
NP - Nepal 3
PE - Perù 3
SN - Senegal 3
TH - Thailandia 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
AZ - Azerbaigian 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
GR - Grecia 2
KE - Kenya 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MN - Mongolia 2
MU - Mauritius 2
PS - Palestinian Territory 2
RO - Romania 2
UY - Uruguay 2
AD - Andorra 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CM - Camerun 1
DK - Danimarca 1
GE - Georgia 1
KG - Kirghizistan 1
KI - Kiribati 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
Totale 11.301
Salva come PNG Salva come JPEG
Città #
Dublin 887
San Jose 860
Chandler 403
Singapore 393
Jacksonville 327
Ashburn 313
Nyköping 286
Hong Kong 280
Dearborn 269
Beijing 217
Dallas 167
Nanjing 145
Santa Clara 141
Lauterbourg 111
Princeton 90
Wilmington 90
Moscow 77
The Dalles 77
Munich 76
Helsinki 73
New York 68
Nanchang 65
Woodbridge 60
Ann Arbor 59
Ho Chi Minh City 52
San Mateo 51
Los Angeles 45
Hanoi 40
Brussels 39
Boardman 37
Des Moines 33
Jiaxing 33
São Paulo 33
Turku 33
Council Bluffs 31
Shenyang 30
Foggia 29
Nuremberg 26
Frankfurt am Main 25
Tianjin 25
Milan 22
Rome 22
Cedar Knolls 21
Changsha 21
Hebei 21
Naples 21
Kunming 19
Chicago 17
Bari 15
Guangzhou 15
Zhengzhou 15
Hangzhou 14
Rio de Janeiro 14
Seattle 14
Warsaw 14
Tokyo 13
Orem 12
San Severo 12
Falkenstein 11
Hilden 11
Ningbo 11
Norwalk 11
Redwood City 11
Taizhou 11
Curitiba 10
Jinan 10
London 10
San Francisco 10
Belo Horizonte 9
Brasília 9
Buffalo 9
Kocaeli 9
Montreal 9
Pimonte 9
Assago 8
Auburn Hills 8
Bologna 8
Boston 8
Fortaleza 8
Johannesburg 8
Lanzhou 8
Atlanta 7
Baghdad 7
Brooklyn 7
Bắc Ninh 7
Falls Church 7
Haiphong 7
Jakarta 7
Ottawa 7
Pune 7
Toronto 7
Vienna 7
Amman 6
Biên Hòa 6
Hanover 6
Madrid 6
Manchester 6
Mumbai 6
Paris 6
Porto Alegre 6
Totale 6.739
Salva come PNG Salva come JPEG
Nome #
Do patients and referral centers characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register 205
Serum Soluble Intercellular Adhesion Molecule-1 in MS: relation to clinical and Gd-MRI activity, and to rIFNβ-1b treatment. 152
Analisi fenotipica di linfociti T di pazienti con Sclerosi multipla (SM) nel sangue periferico ed in coltura con e senza aggiunta di mitogeni 146
Serial immunoprecipitation assays for interferon-(IFN)-beta antibodies in multiple sclerosis patients. 145
Defining the electroclinical phenotype and outcome of PCDH19‐related epilepsy: A multicenter study 145
Anti-Inflammatory and Anti-Oxidant Effect of Dimethyl Fumarate in Cystic Fibrosis Bronchial Epithelial Cells 145
Comparison of Clinical and demographic features between affected pairs of Italian Multiple Sclerosis Multiplex families; relation to Tumor Necrosis Factor genomic polymorphisms. 142
Changes of serum ICAM-1 and MMP-9 induced by rIFNbeta-1b treatment in relapsing-remitting MS. 139
The epilepsy phenotype in adult patients with intellectual disability and pathogenic copy number variants 139
Intravenous lacosamide in seizure emergencies: Observations from a hospitalized in-patient adult population. 139
Adhesion molecules and matrix metalloproteinases in MS: effects induced by Interferon beta. 136
Espressione di LFA-1 su linfociti memoria CD4+CD45RO+ si sangue periferico nella Sclerosi Multipla remittente: effetti indotti dall’ IFN b-1a. 136
Analisi liquorale per la diagnosi ed il follow-up di malattie infiammatorie del SNC. 135
Consensus recommendations of the Italian Association for Neuroimmunology for immunochemical cerebrospinal fluid examination. 134
CSF and serum soluble adhesion molecules in Multiple Sclerosis 133
Disease duration, relapse rate and clinical course in Multiple Sclerosis. Relation to IgG production within the blood-brain barrier. 128
Design of a European multicenter study dedicated to the evaluation of the EDMUS system: EVALUED. 128
Italian cohort of Lafora disease: Clinical features, disease evolution, and genotype-phenotype correlations 128
Usefulness of a standardized method for collecting anamnestic data in multiple sclerosis (MS). 127
Between-laboratory variability in oligoclonal IgG band numbering. 126
Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients. 125
T regulatory cells are markers of disease activity in multiple sclerosis patients. 125
Age-Related Disability in Multiple Sclerosis. 124
New Insights Into Immune Cell-Derived Extracellular Vesicles in Multiple Sclerosis. 123
L’ esame del liquor (CSF) nella diagnosi di Sclerosi Multipla (SM) 122
Counting of peripheral extracellular vesicles in Multiple Sclerosis patients by an improved nanoplasmonic assay and dynamic light scattering 122
European Validation of a Standardized Clinical Description of Multiple Sclerosis. 121
Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple Sclerosis 119
Intrathecal IgG synthesis and clinical course in Multiple Sclerosis 119
Wernicke's encephalopathy following reduced food intake due to depressive disorders. 119
Tremor, sensory-motor polyneuropathy and cerebral gliosis in klinefelter's syndrome 118
Differential regulation of membrane bound and soluble ICAM 1 in human endothelium and blood mononuclear cells: effects of interferon beta-1a. 117
Soluble Intercellular Adhesion Molecule-1 in serum and cerebrospinal fluid (CSF) of clinically active relapsing-remitting multiple sclerosis: correlation with Gd-DTPA Magnetic Resonance Imaging enhancement and CSF findings. 117
Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events. 116
Late-onset Leber hereditary optic neuropathy mimiking Susac’s syndrome 116
Effects of rIFNbeta-1b on serum circulating ICAM-1 in relapsing remitting multiple sclerosis and on the membrane-bound ICAM-1 expression on brain microvascular endothelial cells. 114
First-aid management of tonic-clonic seizures among healthcare personnel: A survey by the Apulian section of the Italian League Against Epilepsy 114
Interferon beta in relapsing / remitting multiple sclerosis: an independent postmarketing study in southern Italy. 112
Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in Multiple Sclerosis: relationships with different MRI measures of disease activity during IFN-beta-1a treatment. 112
MicroRNAs 181a and 125a are highly expressed in naïve RRMS: a pilot case-control study 111
Epstein–Barr virus (EBV) and multiple sclerosis association: EBV has a primary or secondary role? 111
Serum MMP-2 and MMP-9 are elevated in different Multiple Sclerosis subtypes. 111
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 111
Post-marketing of disease modifying drugs in multiple sclerosis: An exploratory analysis of gender effect in interferon beta treatment. 110
Soluble Intercellular adhesion molecule-1 (sICAM-1) in serum and cerebrospinal fluid of demyelinating diseases of the central and the peripheral nervous system. 110
Soluble Intercellular Adhesion Molecule-1 (sICAM-1) nel siero e liquor di pazienti con sclerosi multipla remittente clinicamente attiva: correlazioni con lesioni RMI che assumono gadolinio e con parametri liquorali 110
Il ruolo dell’ esame del liquor 109
Effect of fingolimod action on the release of monocyte-derived microvesicles in multiple sclerosis patients. 109
Prognostic indicators in pediatric clinically isolated syndrome. 109
An Italian multicentre study of perampanel in progressive myoclonus epilepsies 109
Immune and central nervous system-related miRNAs expression profiling in monocytes of multiple sclerosis patients. 108
Krebs cycle derivatives, dimethyl fumarate and itaconate, control metabolic reprogramming in inflammatory human microglia cell line 107
Quantitation of intrathecal measles virus IgG antibody synthesis rate: Subacute sclerosing panencephalitis and multiple sclerosis. 105
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register 105
LFA-1 expressing CD4+CD45RO+ peripheral blood T-lymphocytes in RR MS: effects induced by rIFNbeta-1a. 104
Glatiramer Acetate in Multiple Sclerosis: a review 104
Pharmacological treatment of depression in Alzheimer's disease: A challenging task 104
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 104
Brivaracetam in Absence Status Epilepticus 103
Usefulness of a standardised collection of disease events for clinical studies in Multiple Sclerosis. 102
Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis. 101
Perceptive and Subjective Evaluation of Speech Disorders in Parkinson's Disease 100
Effetti antinfiammatori dell’ Interferone beta-1b ricombinante nella Sclerosi Multipla: studio longitudinale dei livelli sierici della forma solubile di Intercellular Adhesion Molecule-1 (sICAM-1) e dei subsets linfocitari 99
P2X7 purinergic receptor on monocytes of patients with Multiple Sclerosis: effects of Glatiramer Acetate immune modulation 99
How the cognitive reserve interacts with β-amyloid deposition in mitigating FDG metabolism: An observational study. 98
Faciobrachial dystonic seizures expressed as epileptic spasms, followed by focal seizures in anti-LGI1 encephalitis: a video-polygraphic study. 98
IMMUNOSENESCENCE AND MULTIPLE SCLEROSIS: PROGNOSTIC AND THERAPEUTIC IMPLICATIONS 97
Glatiramer Acetate induces pro-apoptotic mechanisms involving Bcl-2, Bax and Cyt-c in peripheral lymphocytes from Multiple Sclerosis patients. 96
From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases 96
Real world comparison of teriflunomide and dimethyl fumarate in naïve relapsing multiple sclerosis patients: Evidence from the Italian MS register 96
Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives 96
Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register. 94
Association of Loneliness with Functional and Cognitive Status in Minor and Major Neurocognitive Disorders 93
Comparing STRATIFY JCV™ DxSelect™ and IMMUNOWELL™ JCV IgG Tests in RRMS to Assess PML Risk 92
Fisiopatologia della risposta immunitaria nel compartimento liquorale. XXXVII Congress of the Italian Neurological Society, Bari 14-18 October 2006. 92
Interaction between Cognitive Reserve and Biomarkers in Alzheimer Disease 92
The effect of quarantine due to Covid-19 pandemic on seizure frequency in 102 adult people with epilepsy from Apulia and Basilicata regions, Southern Italy 90
Mesenchymal Stem Cell-Derived Extracellular Vesicles and Their Therapeutic Use in Central Nervous System Demyelinating Disorders 90
Fluctuations of MS births and UV-light exposure. 89
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic 88
Weight loss and decubitus duodenal ulcer in Parkinson's disease treated with levodopa-carbidopa intestinal gel infusion. 86
Editorial: Immunosenescence and multiple sclerosis: Prognostic and therapeutic implications 85
The Italian multiple sclerosis register 85
IgG and IgM antibodies to the refolded MOG(1-125) extracellular domain in humans. 83
Molecular Characterization of Peripheral Extracellular Vesicles in Clinically Isolated Syndrome: Preliminary Suggestions from a Pilot Study 82
Monocytes P2X7 purinergic receptor is modulated by glatiramer acetate in multiple sclerosis. 81
Metabolic reprogramming in inflammatory microglia indicates a potential way of targeting inflammation in Alzheimer's disease 80
Multiple Sclerosis Treatments Affect Monocyte-Derived Microvesicle Production. 80
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration 80
Stopping Interferon Beta 1b Does Not Influence the Risk of Disability Accrual in Non-Active SPMS: Results from an Italian Real-World Study 79
An Association of Framingham Risk Score with Patient Determined Disease Steps in a Cohort of Relapsing-Remitting Multiple Sclerosis Patients: An Italian Real-World Monocentric Experience 78
First-line therapies in Late Onset Multiple Sclerosis: an Italian registry study 76
Evaluating Cognitive Outcomes in Multiple Sclerosis: Real-World Impact of Ozanimod on Processing Speed Using BICAMS 75
Treatment with metformin in twelve patients with Lafora disease 75
Guillain-Barré syndrome as only manifestation of COVID-19 infection 71
Unraveling the inflammation-degeneration tangle in early MS: preliminary insights from ferritin, neurogranin, TREM2, and retinal ganglion cell layer 69
Synergistic interaction of fatty acids and oxysterols impairs mitochondrial function and limits liver adaptation during nafld progression (Q1 WoS) 69
Lactobacilli Cell-Free Supernatants Modulate Inflammation and Oxidative Stress in Human Microglia via NRF2-SOD1 Signaling 67
Personality Traits and Fatigue in Multiple Sclerosis: A Narrative Review 66
Myeloid-derived Suppressor Cells and Multiple Sclerosis 65
Totale 10.747
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.445
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.445
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 0 0 4
2021/2022540 70 12 16 15 41 10 19 30 66 56 40 165
2022/20232.491 198 129 105 157 119 191 18 144 1.049 117 186 78
2023/2024389 65 55 23 24 43 69 32 17 4 8 18 31
2024/20252.252 64 37 55 54 57 247 194 174 483 156 247 484
2025/20264.052 222 446 395 524 223 191 749 376 350 249 131 196
Totale 12.394